You have 9 free searches left this month | for more free features.

Condition

Locally Advanced or Metastatic Urothelial Carcinoma (1)

Urothelial Carcinoma (1)

Overall Status

Active, not recruiting (2)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Hoffmann-La Roche (1)

Spanish Oncology Genito-Urinary Group (1)

Collaborator

Roche Pharma AG (1)

Intervention

atezolizumab (1)

atezolizumab 1200 mg/m2 (1)

carboplatin (1)

cisplatin (1)

cisplatin 70 mg/m2 (1)

gemcitabine (1)

gemcitabine 1000 mg/m2 (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

IMvigor130

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Urothelial Carcinoma Trial in Worldwide (Atezolizumab, Carboplatin, Gemcitabine)

Active, not recruiting

Urothelial Carcinoma

Atezolizumab
+4 more

Springdale, Arkansas
+223 more

Jan 5, 2023

Locally Advanced or Metastatic Urothelial Carcinoma Trial in Spain (Atezolizumab 1200 mg/m2, Gemcitabine 1000 mg/m2, Cisplatin

Active, not recruiting

Locally Advanced or Metastatic Urothelial Carcinoma

Atezolizumab 1200 mg/m2
+2 more

Barcelona, Spain
+11 more

Mar 24, 2022